Trimel to Present at the JMP Securities Healthcare Conference
18 Junho 2014 - 4:00PM
Marketwired
Trimel to Present at the JMP Securities Healthcare Conference
TORONTO, ONTARIO--(Marketwired - Jun 18, 2014) - Trimel
Pharmaceuticals Corporation (TSX:TRL) today announced that
management is scheduled to present an overview of the Company at
the JMP Securities Healthcare Conference at the Westin New York
Grand Central, New York on June 24, 2014 at 12:00 p.m. (Eastern
time). The presentation materials will also be made available on
the Trimel website at www.trimelpharmaceuticals.com.
For further information regarding Trimel Pharmaceuticals
Corporation, please contact Kenneth Howling, Chief Financial
Officer at (416) 679-0536 or Trimel via email at
ir@trimelpharmaceuticals.com.
About Trimel
Trimel is a specialty pharmaceutical company actively developing
medications for male hypogonadism, female sexual dysfunction and
various respiratory disorders. Natesto™, a product utilizing
Trimel's licensed bioadhesive nasal gel technology, has been
approved for sale in the United States by the FDA. For more
information, please visit www.trimelpharmaceuticals.com???.
Trimel Pharmaceuticals CorporationKenneth HowlingChief Financial
Officer(416)
679-0536ir@trimelpharmaceuticals.comwww.trimelpharmaceuticals.com
Trilogy International Pa... (TSX:TRL)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Trilogy International Pa... (TSX:TRL)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024
Notícias em tempo-real sobre Trilogy International Partners Inc da Toronto Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Trimel Pharmaceuticals Corp